Array Behavioral Care Launches Rapid Care for Urgent Needs
Philadelphia, Pennsylvania, U.S., September 18, 2026 Array Behavioral Care, a provider of virtual behavioral health services, has introduced Array...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Philadelphia, Pennsylvania, U.S., September 18, 2026 Array Behavioral Care, a provider of virtual behavioral health services, has introduced Array...
BALTIMORE, July 17, 2026 Medifast, Inc. has announced the launch of Trilivyâ„¢, a comprehensive science-backed metabolic health system that...
BOSTON, Mass., July 7, 2026 Handspring Health has secured $19 million in Series B financing, with Angelini Ventures participating...
FORT LAUDERDALE, Fla., July 7, 2026 Splash Beverage Group, Inc. has announced the acquisition of exclusive global licensing rights...
NEW YORK, July 7, 2026 The American Parkinson Disease Association (APDA) has announced the launch of “Bridging Mental Health...
NEW TAIPEI CITY, Taiwan, June 11, 2026 GlycoNex, Inc. (GNX) announced positive topline results from its Phase III clinical...
NEWPORT BEACH, Calif., June 11, 2026 Wave Neuroscience announced that the U.S. Food and Drug Administration (FDA) has granted...
